MTN-041/ MAMMA

Status

Ongoing

Phase

Other

Objective

Qualitative assessment of acceptability of vaginal ring (VR) and oral pre-exposure prophylaxis (PrEP) use during pregnancy and breastfeeding

*Study has been closed to follow-up*

Last updated May 2, 2021

Prevention Option(s)

Microbicides

PrEP

Observational

Cross-sectional

Arms and Assigned Interventions

Products

Dapivirine Ring

TDF/FTC (Truvada)

Official Code

Trial Sponsors

NIAID (DAIDS-ES: 38161)

May 2018

November 2018

Enrollment

240

Population

Women

Sites

Malawi

South Africa

Kampala

Uganda

Harare

Zimbabwe

You are here